Sigara içenlerde COVID-19 hastalığı geçirmenin sigara içme alışkanlığına etkisi

Amaç: COVİD-19 hastalığına yakalanmış sigara içicilerinde, bu enfeksiyona bağlı sigara içme alışkanlığında meydana gelen değişikliklerin değerlendirilmesi amaçlanmıştır. Gereç ve Yöntem: Tanımlayıcı kesitsel türdeki bu çalışma, Ekim ve Kasım 2021 tarihleri arasında COVID-19'lu 312 aktif sigara içicisi ile yürütülmüştür. Bulgular: Sigara içerken COVID-19 geçirenlerin %38,6'sının (n=81) sigarayı azalttığı, %2,4'ünün (n=5) sigarayı bıraktığı, %9,5'inin (n=20) ise bir süre bırakıp sonra yeniden başladığı belirlendi. 45 yaş üstü bireylerin sigara içerken COVID-19 kaptığı (p=0,011) ve 1-5 yıl eğitim alanların 6-12 yıl ve 13 yıl ve üzeri eğitim alanlara göre (p:0,012; p:0,010) sigarayı bırakma isteğini artırdı. Sonuç: Pandemi sürecinde sigaranın sağlığa zararları ve sigarayı bırakmanın gerekliliği konulu kamu spotları daha aktif bir şekilde paylaşılabilirdi. Ayrıca danışmanlık, nikotin bantları ve ilaç tedavisi gibi sigarayı bırakma tedavileri daha yaygın olarak sunulabilirdi. Sigarayı bırakmak için bir fırsat olan bu COVID-19 pandemisi ne yazık ki tam olarak değerlendirilememiştir ve bu alışkanlığı bırakma konusunda olumlu sonuçlar alınamamıştır.

Anahtar Kelimeler:

Sigara bırakma, Sigara içmek, Pandemiler, COVID-19

The effects of being infected with COVID-19 in smokers on their smoking habits

Aim: It is aimed to investigate the attitude and behaviour changes in the smoking habit of those who had COVID-19 while smoking. Materials and Methods: This descriptive cross-sectional study was conducted with 312 active smokers with Coranavirus disease (COVID-19) between October and November 2021. Results: It was determined that 38.6% (n=81) of those who had COVID-19 while smoking reduced smoking, 2.4% (n=5) quit smoking, and 9.5% (n=20) quit for a while and then restarted. It was determined that individuals over the age of 45 who had COVID-19 while smoking (p=0.011) and those who received 1-5 years of education compared to those with education of 6-12 years and 13 years or more (p:0.012; p:0.010 respectively) developed more desire to quit smoking. Conclusion: Public service ads on the health hazards of smoking and the need to quit smoking could have been shared more actively during the pandemic. Also, smoking cessation treatments such as counselling, nicotine patches and medication could have been offered more widely. This COVID-19 Pandemic period, which is an opportunity to quit smoking, unfortunately could not be fully utilized and positive results could not be obtained in this habit.

Keywords:

Smoking cessation, Smoking, Pandemics, COVID-19,

PDF

___

de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14(8):523-534. doi:10.1038/nrmicro.2016.81
Dhama K, Khan S, Tiwari R, et al. Coronavirus Disease 2019-COVID-19. Clin Microbiol Rev. 2020;33(4):e00028-20. doi:10.1128/CMR.00028-20
World Health Organization. 2021. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int. Accessed November 24, 2021.
Lippi G, Henry BM. Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19). Eur J Intern Med. 2020;75:107-108. doi:10.1016/j.ejim.2020.03.014
Shastri MD, Shukla SD, Chong WC, et al. Smoking and COVID-19: What we know so far. Respir Med. 2021;176:106237. doi:10.1016/j.rmed.2020.106237
Alqahtani JS, Oyelade T, Aldhahir AM, et al. Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis. PLoS One. 2020;15(5):e0233147. doi:10.1371 /journal.pone. 0233147
Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2021;1-18. doi:10.1038/s41580-021-00418-x
Leung JM, Yang CX, Sin DD. COVID-19 and nicotine as a mediator of ACE-2. Eur Respir J. 2020;55(6):2001261. doi:10.1183/13993003.01261-2020
Russo P, Bonassi S, Giacconi R, et al. COVID-19 and smoking: is nicotine the hidden link?. Eur Respir J. 2020;55(6):2001116. doi:10.1183/13993003.01116-2020
Kashyap VK, Dhasmana A, Massey A, et al. Smoking and COVID-19: Adding Fuel to the Flame. Int J Mol Sci. 2020;21(18):6581. doi:10.3390/ijms21186581
World Health Organization. News: Tobacco use falling. https://www.who.int/news/item/16-11-2021-tobacco-use-falling-who-urges-countries-to-invest-in-helping-more-people-to-quit-tobacco. Accessed November 24, 2021.
Arpacıoğlu S, Ünübol B. Investigation of Changes in Alcohol-Smoking Usage and Related Situations in the Coronavirus Outbreak., Cyprus Turkish Journal of Psychiatry & Psychology. 2020:2(3): 128-138. doi:10.35365/ctjpp.20.03.23
Altuntas SB, Ozkaya H, Besel A, Namlı SB, Albayrak K. COVID-19 Anxiety Level in Patients Applying to the Smoking Cessation Clinic. Paper presented at: 21st National Family Medicine Congress. Ankara. 11-14 November 2021.
T.C. Sağlık Bakanlığı, COVID-19 Bilgilendirme Platformu, https://covid19.saglik.gov.tr/. Accessed November 28, 2021.
Türkiye İstatistik Kurumu. Ulusal Veri Sayfası. https://data.tuik.gov.tr/Search/Search?text=t%C3%BCt%C3%BCn&dil=1 Accessed November 24, 2021.
Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86(9):1119-1127. doi:10.1111/j.1360-0443.1991.tb01879.x
Uysal MA, Kadakal F, Karşidağ C, Bayram NG, Uysal O, Yilmaz V. Fagerstrom test for nicotine dependence: reliability in a Turkish sample and factor analysis. Tuberk Toraks. 2004;52(2):115-121.
Rempala G, Wesolowski J, Asymptotics for Products of Sums and U-Statistics, Electronic Communications in Probability, 2002;7(7):47-54.
Albayrak A, Eroğlu A, Kalaycı Ş, Küçüksille E, Ak B, Karaatlı M ve Keskin H. SPSS Uygulamalı Çok Değişkenli İstatistik Teknikleri. 1nd Edition, Ankara: Asil Yayınevi; 2005:131-132.
Sim YS, Yoo S, Lee KS, Rhee CK, Kim YK. Associations of clinical, psychological, and socioeconomic characteristics with nicotine dependence in smokers. Sci Rep. 2021;11(1):18544. doi:10.1038/s41598-021-97387-0
Gallus S, Lugo A, Liu X, et al. Who Smokes in Europe? Data From 12 European Countries in the TackSHS Survey (2017-2018). J Epidemiol. 2021;31(2):145-151. doi:10.2188/jea.JE20190344
Picco L, Subramaniam M, Abdin E, Vaingankar JA, Chong SA. Smoking and nicotine dependence in Singapore: findings from a cross-sectional epidemiological study. Ann Acad Med Singap. 2012;41(8):325-334.
Klemperer EM, West JC, Peasley-Miklus C, Villanti AC. Change in Tobacco and Electronic Cigarette Use and Motivation to Quit in Response to COVID-19. Nicotine Tob Res. 2020;22(9):1662-1663. doi:10.1093/ntr/ntaa072
Pennanen M, Broms U, Korhonen T, et al. Smoking, nicotine dependence and nicotine intake by socio-economic status and marital status. Addict Behav. 2014;39(7):1145-1151. doi:10.1016/j.addbeh.2014.03.005
Bosdriesz JR, Willemsen MC, Stronks K, Kunst AE. Tobacco control policy and socio-economic inequalities in smoking in 27 European countries. Drug Alcohol Depend. 2016;165:79-86. doi:10.1016/j.drugalcdep.2016.05.020
Pipkin JA, Cruz B, Flores RJ, et al. Both nicotine reward and withdrawal are enhanced in a rodent model of diabetes. Psychopharmacology (Berl). 2017;234(9-10):1615-1622. doi:10.1007/s00213-017-4592-y
Kayhan TB, Gedik TI, Taş S. The Effect of the COVID-19 Pandemic on Smoking Cessation Success. J Community Health. 2021;46(3):471-475. doi:10.1007/s10900-020-00880-2
Li Y, Luk TT, Wu Y, et al. High Perceived Susceptibility to and Severity of COVID-19 in Smokers Are Associated with Quitting-Related Behaviors. Int J Environ Res Public Health. 2021;18(20):10894. doi:10.3390/ijerph182010894.